Should Infliximab be Used as an Adjuvant to IVIG in the Treatment of Children With Kawasaki Disease Who Are at High Risk for Resistance to Conventional Therapy?

被引：0
|
作者：
Shelby Davies
Gabrielle Gold-von Simson
机构：
[1] New York University School of Medicine,
来源：
Pediatric Cardiology | 2013年 / 34卷
关键词：
Vasculitis; Infliximab; Kawasaki Disease; Artery Aneurysm; IVIG Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1756 / 1756
相关论文
共 8 条
  • [1] Should Infliximab be Used as an Adjuvant to IVIG in the Treatment of Children With Kawasaki Disease Who Are at High Risk for Resistance to Conventional Therapy?
    Davies, Shelby
    Gold-von Simson, Gabrielle
    PEDIATRIC CARDIOLOGY, 2013, 34 (07) : 1756 - 1756
  • [2] Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone, Pei-Ni
    Anderson, Marsha S.
    Mulvahill, Matthew J.
    Heizer, Heather
    Glode, Mary P.
    Dominguez, Samuel R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (10) : 976 - 980
  • [3] Efficacy and Limitation of Infliximab Treatment for Children with Kawasaki Disease Intractable to Intravenous Immunoglobulin Therapy: Report of an Open-label Case Series
    Mori, Masaaki
    Imagawa, Tomoyuki
    Hara, Ryoki
    Kikuchi, Masako
    Hara, Takuma
    Nozawa, Tomo
    Miyamae, Takako
    Yokota, Shumpei
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (04) : 864 - 867
  • [4] The risk of hospitalization for respiratory tract infection (RTI) in children who are treated with high-dose IVIG in Kawasaki Disease:a nationwide population-based matched cohort study
    Lei, Wei-Te
    Lin, Chien-Yu
    Kao, Yu-Hsuan
    Lee, Cheng-Hung
    Lin, Chao-Hau
    Shyur, Shyh-Dar
    Yang, Kuender-Der
    Chen, Jian-Han
    PEERJ, 2018, 6
  • [5] Methylprednisolone pulse and prednisolone for intensification of primary treatment in Kawasaki disease patients at high risk of treatment resistance: a multicenter prospective cohort study
    Miura, Masaru
    Miyata, Koichi
    Kaneko, Tetsuji
    Akahoshi, Shogo
    Morikawa, Yoshihiko
    Matsushima, Takahiro
    Sakakibara, Hiroshi
    Kobayashi, Tohru
    Nakamura, Takahiro
    Takahashi, Tsutomu
    Nakazawa, Maki
    Shibata, Akimichi
    Yamagishi, Hiroyuki
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (10) : 4265 - 4274
  • [6] Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study
    Yukako Yoshikane
    Yoshiaki Okuma
    Tatsuki Miyamoto
    Junichi Hashimoto
    Ryuji Fukazawa
    Taichi Kato
    Atsuhito Takeda
    Kenji Suda
    Takeji Matsushita
    Michiaki Hiroe
    Kyoko Imanaka-Yoshida
    Pediatric Rheumatology, 19
  • [7] Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study
    Yoshikane, Yukako
    Okuma, Yoshiaki
    Miyamoto, Tatsuki
    Hashimoto, Junichi
    Fukazawa, Ryuji
    Kato, Taichi
    Takeda, Atsuhito
    Suda, Kenji
    Matsushita, Takeji
    Hiroe, Michiaki
    Imanaka-Yoshida, Kyoko
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [8] Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment
    Murayama, Yuri
    Hamada, Hiromichi
    Shiko, Yuki
    Onouchi, Yoshihiro
    Kakimoto, Nobuyuki
    Ozawa, Yoshihito
    Hanaoka, Hideki
    Hata, Akira
    Suzuki, Hiroyuki
    FRONTIERS IN PEDIATRICS, 2023, 11
1